Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
Fiche publication
Date publication
novembre 2022
Journal
Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PIVOT Xavier, Dr SCHOTT Roland, Pr FAVRET Fabrice, Dr HUCTEAU Elyse, Dr MALLARD Joris
Tous les auteurs :
Mallard J, Hucteau E, Schott R, Trensz P, Pflumio C, Kalish-Weindling M, Favret F, Pivot X, Hureau TJ, Pagano AF
Lien Pubmed
Résumé
Fatigue is a hallmark of breast cancer and is associated with skeletal muscle deconditioning. If cancer-related fatigue occurs early during chemotherapy (CT), the development of skeletal muscle deconditioning and its effect on exercise capacity remain unclear. The aim of this study was to investigate the evolution of skeletal muscle deconditioning and exercise capacity in patients with early-stage breast cancer during CT.
Mots clés
cancer-related fatigue, exercise capacity, muscle atrophy, muscle fatigue, muscle force
Référence
Cancer. 2022 11 17;: